Clinical Trial Detail

NCT ID NCT02285959
Title Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Erol Veznedaroglu
Indications

glioblastoma multiforme

Therapies

Bevacizumab

Age Groups: adult

No variant requirements are available.